Your browser doesn't support javascript.
loading
Individualized surgical treatment of Chiari 1 malformation: A single-center experience.
Khalaveh, Farjad; Steiner, Irene; Reinprecht, Andrea; Czech, Thomas; Kasprian, Gregor; Rössler, Karl; Dorfer, Christian.
Afiliação
  • Khalaveh F; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.
  • Steiner I; Center for Medical Data Science, Institute of Medical Statistics, Medical University of Vienna, Vienna, Austria.
  • Reinprecht A; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.
  • Czech T; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.
  • Kasprian G; Department of Radiology, Division of Neuro, and Musculoskeletal Radiology, Medical University of Vienna, Vienna, Austria.
  • Rössler K; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.
  • Dorfer C; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria. Electronic address: christian.dorfer@meduniwien.ac.at.
Clin Neurol Neurosurg ; 230: 107803, 2023 07.
Article em En | MEDLINE | ID: mdl-37245455
ABSTRACT

OBJECTIVE:

To present our experience with an individualized surgical approach to treat Chiari malformation type 1.

METHODS:

Based on (1) neurological symptoms, (2) the existence and extent of a syrinx and (3) the degree of the tonsillar descent we performed four types of approaches on a case-by-case basis in 81 patients (1) foramen magnum decompression (FMD) with dura splitting (FMDds); (2) FMD with duraplasty (FMDdp); (3) FMD with duraplasty and tonsillar manipulation (FMDao); and (4) tonsillar resection/reduction (TR). Patient characteristics, Chiari Severity Index (CSI), fourth ventricular roof angle (FVRA) and Chicago Chiari Outcome Scale (CCOS) were analyzed.

RESULTS:

CCOS was between 13 and 16 points in 8/11 (73 %) patients after FMDds, 38/45 (84 %) patients after FMDdp, and 24/24 (100 %, one patient lost to follow-up) patients after TR. We experienced an overall complication rate of 13.6 % (11/81) in this series, whereas seven of these eleven complications (64 %) occurred in the FMDao group and the complication rate increased with the invasiveness of the approach (0 % FMDds; 4 % FMDdp; 12 % TR).

CONCLUSION:

Given the clear correlation between the extend of the approach and the complication rate the least invasive approach necessary to achieve clinical improvement should be selected. Due to the high complication rates, FMDao should not be used as a treatment option. The severity of the tonsillar descent, basilar invagination and current CM1 scores could be used to aid in the approach selection.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Platibasia / Malformação de Arnold-Chiari Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Platibasia / Malformação de Arnold-Chiari Idioma: En Ano de publicação: 2023 Tipo de documento: Article